133 related articles for article (PubMed ID: 31517614)
1. Enhanced intestinal 2-deoxy-2-[18F]fluoro-D-glucose uptake under metformin is not fully suppressed by loperamide.
Nobashi T; Saga T; Nakamoto Y; Shimizu Y; Koyasu S; Ishimori T; Watanabe M; Kimura H; Togashi K
Endocr Regul; 2018 Oct; 52(4):185-191. PubMed ID: 31517614
[TBL] [Abstract][Full Text] [Related]
2. Clearance of the high intestinal (18)F-FDG uptake associated with metformin after stopping the drug.
Ozülker T; Ozülker F; Mert M; Ozpaçaci T
Eur J Nucl Med Mol Imaging; 2010 May; 37(5):1011-7. PubMed ID: 20107796
[TBL] [Abstract][Full Text] [Related]
3. 18F-FDG uptake in the colon is modulated by metformin but not associated with core body temperature and energy expenditure.
Bahler L; Holleman F; Chan MW; Booij J; Hoekstra JB; Verberne HJ
PLoS One; 2017; 12(5):e0176242. PubMed ID: 28464031
[TBL] [Abstract][Full Text] [Related]
4. Enhanced Release of Glucose Into the Intraluminal Space of the Intestine Associated With Metformin Treatment as Revealed by [
Morita Y; Nogami M; Sakaguchi K; Okada Y; Hirota Y; Sugawara K; Tamori Y; Zeng F; Murakami T; Ogawa W
Diabetes Care; 2020 Aug; 43(8):1796-1802. PubMed ID: 32493754
[TBL] [Abstract][Full Text] [Related]
5. Impact of medication discontinuation on increased intestinal FDG accumulation in diabetic patients treated with metformin.
Oh JR; Song HC; Chong A; Ha JM; Jeong SY; Min JJ; Bom HS
AJR Am J Roentgenol; 2010 Dec; 195(6):1404-10. PubMed ID: 21098202
[TBL] [Abstract][Full Text] [Related]
6. Metformin-related colonic glucose uptake; potential role for increasing glucose disposal?--A retrospective analysis of (18)F-FDG uptake in the colon on PET-CT.
Bahler L; Stroek K; Hoekstra JB; Verberne HJ; Holleman F
Diabetes Res Clin Pract; 2016 Apr; 114():55-63. PubMed ID: 27103370
[TBL] [Abstract][Full Text] [Related]
7. High and typical 18F-FDG bowel uptake in patients treated with metformin.
Gontier E; Fourme E; Wartski M; Blondet C; Bonardel G; Le Stanc E; Mantzarides M; Foehrenbach H; Pecking AP; Alberini JL
Eur J Nucl Med Mol Imaging; 2008 Jan; 35(1):95-9. PubMed ID: 17786437
[TBL] [Abstract][Full Text] [Related]
8. Metformin Promotes 2-Deoxy-2-[
Wang Z; Kang F; Gao Y; Liu Y; Xu X; Ma X; Ma W; Yang W; Wang J
Mol Imaging Biol; 2018 Jun; 20(3):388-397. PubMed ID: 29256045
[TBL] [Abstract][Full Text] [Related]
9. Metformin discontinuation less than 72 h is suboptimal for F-18 FDG PET/CT interpretation of the bowel.
Lee SH; Jin S; Lee HS; Ryu JS; Lee JJ
Ann Nucl Med; 2016 Nov; 30(9):629-636. PubMed ID: 27392947
[TBL] [Abstract][Full Text] [Related]
10. Metformin temporal and localized effects on gut glucose metabolism assessed using 18F-FDG PET in mice.
Massollo M; Marini C; Brignone M; Emionite L; Salani B; Riondato M; Capitanio S; Fiz F; Democrito A; Amaro A; Morbelli S; Piana M; Maggi D; Cilli M; Pfeffer U; Sambuceti G
J Nucl Med; 2013 Feb; 54(2):259-66. PubMed ID: 23287574
[TBL] [Abstract][Full Text] [Related]
11. Discontinuation of metformin to prevent metformin-induced high colonic FDG uptake: is 48 h sufficient?
Schreuder N; Klarenbeek H; Vendel BN; Jager PL; Kosterink JGW; van Puijenbroek EP
Ann Nucl Med; 2020 Nov; 34(11):833-839. PubMed ID: 32815120
[TBL] [Abstract][Full Text] [Related]
12. Metformin Discontinuation prior to FDG PET/CT: A Randomized Controlled Study to Compare 24- and 48-hour Bowel Activity.
Hamidizadeh R; Eftekhari A; Wiley EA; Wilson D; Alden T; Bénard F
Radiology; 2018 Nov; 289(2):418-425. PubMed ID: 30106348
[TBL] [Abstract][Full Text] [Related]
13. Influence of bowel preparation before 18F-FDG PET/CT on physiologic 18F-FDG activity in the intestine.
Soyka JD; Strobel K; Veit-Haibach P; Schaefer NG; Schmid DT; Tschopp A; Hany TF
J Nucl Med; 2010 Apr; 51(4):507-10. PubMed ID: 20237041
[TBL] [Abstract][Full Text] [Related]
14. Molecular imaging of murine intestinal inflammation with 2-deoxy-2-[18F]fluoro-D-glucose and positron emission tomography.
Brewer S; McPherson M; Fujiwara D; Turovskaya O; Ziring D; Chen L; Takedatsu H; Targan SR; Wei B; Braun J
Gastroenterology; 2008 Sep; 135(3):744-55. PubMed ID: 18639553
[TBL] [Abstract][Full Text] [Related]
15. The effect of additional acarbose on metformin-associated artificially high
Urhan E; Temizer E; Karaca Z; Abdulrezzak U; Kara CS; Hacioglu A; Unluhizarci K
Acta Diabetol; 2022 Jul; 59(7):929-937. PubMed ID: 35429263
[TBL] [Abstract][Full Text] [Related]
16. Rifaximin suppresses background intestinal 18F-FDG uptake on PET/CT scans.
Franquet E; Palmer MR; Gifford AE; Selen DJ; Chen YC; Sedora-Roman N; Joyce RM; Kolodny GM; Moss AC
Nucl Med Commun; 2014 Oct; 35(10):1026-31. PubMed ID: 25076161
[TBL] [Abstract][Full Text] [Related]
17. Changes in [18F]Fluoro-2-deoxy-D-glucose incorporation induced by doxorubicin and anti-HER antibodies by breast cancer cells modulated by co-treatment with metformin and its effects on intracellular signalling.
Cooper AC; Fleming IN; Phyu SM; Smith TA
J Cancer Res Clin Oncol; 2015 Sep; 141(9):1523-32. PubMed ID: 25579456
[TBL] [Abstract][Full Text] [Related]
18. Gastrointestinal uptake of FDG after N-butylscopolamine or omeprazole treatment in the rat.
Yamamoto F; Nakada K; Zhao S; Satoh M; Asaka M; Tamaki N
Ann Nucl Med; 2004 Oct; 18(7):637-40. PubMed ID: 15586641
[TBL] [Abstract][Full Text] [Related]
19. 18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) for assessment of enteropathy-type T cell lymphoma.
Hoffmann M; Vogelsang H; Kletter K; Zettinig G; Chott A; Raderer M
Gut; 2003 Mar; 52(3):347-51. PubMed ID: 12584214
[TBL] [Abstract][Full Text] [Related]
20. O-(2-[(18)F]Fluoroethyl)- L-tyrosine (FET): a tracer for differentiation of tumour from inflammation in murine lymph nodes.
Rau FC; Weber WA; Wester HJ; Herz M; Becker I; Krüger A; Schwaiger M; Senekowitsch-Schmidtke R
Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):1039-46. PubMed ID: 12173018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
